Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-005548
Filing Date
2021-05-18
Accepted
2021-05-18 18:55:38
Documents
2
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1655
2 ex24hannah.txt EX-24 3354
  Complete submission text file 0001179110-21-005548.txt   6330
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913
Business Address
HANNAH ALISON L. (Reporting) CIK: 0001645600 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-29889 | Film No.: 21937796